Flammer Martina M.D.'s Form 4 filing
INSMED Inc (INSM) · filed Nov 13, 2025
- Accession no.
- 0001796960-25-000006
- Filed
- Nov 13, 2025
- Trade date
- Nov 11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.92M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flammer Martina M.D.CIK 0001796960 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | Common Stock | MOption exerciseAcquired | +12,949 | $17.07 | +$221,039.43 | 96,060 | Direct | |
| Nov 11, 2025 | Common Stock | MOption exerciseAcquired | +18,277 | $18.95 | +$346,349.15 | 114,337 | Direct | |
| Nov 11, 2025 | Common Stock | SSaleDisposed | −5,467 | $188.38F2 | −$1,029,873.46 | 108,870 | Direct | |
| Nov 11, 2025 | Common Stock | SSaleDisposed | −12,224 | $189.36F3 | −$2,314,736.64 | 96,646 | Direct | |
| Nov 11, 2025 | Common Stock | SSaleDisposed | −10,622 | $190.33F4 | −$2,021,685.26 | 86,024 | Direct | |
| Nov 11, 2025 | Common Stock | SSaleDisposed | −2,913 | $191.04F5 | −$556,499.52 | 83,111 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | Common Stock | MOption exerciseDisposed | −12,949 | $0.00 | $0 | 12,949 | Direct | |
| Nov 11, 2025 | Common Stock | MOption exerciseDisposed | −18,277 | $0.00 | $0 | 54,833 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 5,467 shares sold at prices ranging from $187.93 to $188.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 12,224 shares sold at prices ranging from $188.90 to $189.88 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 10,622 shares sold at prices ranging from $189.92 to $190.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F5
This is the weighted average sales price representing 2,913 shares sold at prices ranging from $190.94 to $191.14 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.